Next Generation Sequencing (NGS) Market 2018 – 2026 | Global Industry Analysis by Key Players, Trends, Sale, Demand and Segmentation

Next Generation Sequencing (NGS), is a DNA sequencing technology. The process of DNA sequencing, which decides the exact order of nucleotides inside a DNA molecule, is known as Next generation sequencing. Next generation sequencing is high throughput sequencing.  Using next generation sequencer, the process produces a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. Roche 454 sequencing and Illumina sequencing are the modern technologies of next generation sequencing. In comparison to Sanger’s sequencing method, the next generation sequencing is much cost-effective technique that provides better outcomes for DNA sequencing. An entire human genome can be sequenced in a single day using next generation sequencing, however, the Sanger sequencing technology, used to decode the human genome, required over a decade to bring the final summary.

Request Sample for more Professional and Technical insights @

http://bit.ly/2DzZBjY

By providing high flexibility, speed, throughput, and reduced sequencing cost, the introduction of next generation sequencing technologies has brought significant changes in sequencing technologies. In the single sequencing run, the next generation sequencing has ability to generate of nucleotide sequence data. The applications of next generation sequencing are in the field of cancer research, genetic disease research, personalized medicines, biological drug discovery, newborn sequencing metgenomics, and agriculture research etc. Moreover, non-coding RNA expression profiling, identification of binding sites on transcriptional factor, and re- sequencing of targets are some more applications of next generation sequencing.

According to a new study published by Polaris Market Research, the Next Generation Sequencing (NGS) Market is anticipated to reach USD 16.6 billion by 2025.

The adoption of next generation sequencing is mounting for diagnosis of inherited genetic disorders, cancer, HLA typing and identification of infectious diseases as it allows scanning of targeted genome in very small time, and this is expected to propel the growth of Next Generation Sequencing (NGS) Market over the forecast period.

Some of the key players operating in Next Generation Sequencing (NGS) Market are: -

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Roche Holding AG
  • QIAGEN N. V.
  • BGI (Beijing Genomics Institute)
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • GATC Biotech AG
  • Perkin Elme Inc.
  • Agilent Technologies Inc.
  • Macrogen Inc.
  • Eurofins Scientific

For 'Queries' related to this research report, Make an Enquiry @

http://bit.ly/2DzZOUi

Segmentations: -

Next Generation Sequencing (NGS) Market is segmented by application, technology, products and end user.

  • By application, the Next Generation Sequencing (NGS) Market is categorized as, drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others. The drug discovery/personalized medicine segment is estimated to account major share in global next generation sequencing market by application in 2017. The increasing demand of next generation sequencing base test for infectious diseases and cancer, and rising focus on developing and providing next generation sequencing- based diagnostic tests are the major factors contributing towards the high market share of the segment in the global market. Moreover, the growing research and development activities globally are significantly contributing towards the growth of market
  • By Technology, the Next Generation Sequencing (NGS) Market is further sub segmented into Whole Genome Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. By technology, the targeted sequencing & Re-sequencing segment accounted major share in global next generation sequencing market. The targeted sequencing reduces the sequencing cost, and it is target specified and also requires smaller dataset. Moreover, increasing demand target specific genomic studies s expected to propel the growth of segment in the global next generation sequencing market.
  • On the basis of end user, Next Generation Sequencing (NGS) Market is further segmented into healthcare institutions, pharmaceutical & biotechnology companies, research and academic centers, and others. By end user, the research and academics segment accounted major share in global next generation sequencing market. High application of next generation sequencing tools in research is the one of the key factors contributing towards the high market share of the segment. The hospitals and clinics segment is expected to register high CAGR over the forecast period owing to increasing collaboration between hospitals and biotech and pharmaceutical companies to develop advanced test kits for diagnosis of diseases.

TOC of Next Generation Sequencing (NGS) Market:

Chapter 1. Overview and Scope

Chapter 2. Market Summary

Chapter 3 Next Generation Sequencing (NGS) Market Size and Forecast

Chapter 4. Dynamics and Segmentation

Chapter 5. Detailed Insight on Key Company

Chapter 6. Research Methodology and Reference

Chapter 7. Competitive Landscape

TOC Continued…...!!!

 

 

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com

Posted by on Tuesday November 13 2018, 9:12 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in